Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-11-07
1994-06-28
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514385, 514386, 514396, 514553, 514561, 514563, 514564, 514579, 514631, 514638, 514646, A01N 4354, A01N 4350, A61K 31415, A61K 31505
Patent
active
053247310
ABSTRACT:
A method of inhibiting growth, transformation and/or metastasis of mammalian cells, particularly epithelial cells, in which activity of at least one enzyme, which participates in purine metabolism or regulation of nucleotide levels or the relative ratios of their phosphorylated states, is elevated. In particular, a method of inhibiting transformation, growth and/or metastasis of mammalian cells in which a DNA tumor virus, a DNA tumor virus factor or other factor which has an equivalent effect on cells has acted.
REFERENCES:
El Hiyani, L. et al., Biological Abstracts, 84(9): AB-729, No. 89661 (1987). and Chem.-Biol. Interactions, 62: 167-178 (1987).
Toleikis, A. I. et al., Biological Abstracts, 86(11): AB-170, No. 110912 (1988) and Biokhimiya, 53(4): 649-654 (1988).
Moss, R. J. et al., J. Med. Chem., 31: 786-790 (1988).
Kappler, F. et al., J. Med. Chem., 25: 1179-1184 (1982).
Miranda, A. F. et al., Proc. Natl. Acad. Sci., USA, 80: 6581-6585 (1983).
Rubery, E. D. et al., Biological Abstracts, 76(5): 3844, No. 35410 (1983) and Eur. J. Cancer Clin. Oncol. 18(10): 951-956 (1982).
Gazdar, A. F. et al., Biological Abstracts, 805: AB-578, No. 578, No. 41779 (1985) and Cancer Res., 45(6): 2924-2930 (1985).
van der Krol., A. R., J. N. M. Mol, and A. R. Stuitje, BioTechniques, 6(10): 958-976 (1988).
Maker, H. S. et al., Biological Abstracts, 78(2): 1470, No. 12908 (1984), and Res. Comm. Chem. Pathol. Pharmacol., 40(3): 355-366 (1983).
Daouk, G. H. et al., J. Biol. Chem., 263(5): 2442-2446 (Feb. 15, 1988).
Lillie, J. W. et al., Cell, 50: 1091-1100 (1987).
Inhorn, L. et al., Biological Abstrcats, 86(2): AB-700, No. 17059 (1988) and Blood, 71(4): 1003-1011 (1988).
Rivedal, E. and T. Sanner, Chemical Abstracts, 103(9): 50, No. 153568m (1985) and Cancer Lett., 28(1): 9-17 (1985).
Folbergrova, J. et al., Biological Abstracts, 84(2): AB-684, No. 17158 (1987) and Neoplasma, 34(1): 3-14 (1987).
Mariman, E. C. M. et al., Genomics, 1:126-137 (1987).
Mariman, E. C. M. et al., Nucl. Acids Res., 17: 6385 (1989).
Zerler, B. et al., Mol. Cell. Biol., 7: 821-829 (1987).
Shields, R. P. et al., Lab. Invest., 33: 151-158 (1975).
McLaughlin, A. C. et al., J. Biol. Chem., 247: 4382-4388 (1972).
Johnston, J. B. et al., Cancer Res., 46: 2179-2184 (1986).
Kaddurah-Daouk, R. et al., Mol. Cell. Biol., 10(4): 1476-1483 (1990).
Feld, R. and Witte, D. L., Clin. Chem., 23(10): 1930-1932 (1977).
Annesley, T. M. and J. B. Walker, J. Biol. Chem., 253: 8120-8125 (1978).
Silverman, L. M. et al., Clin. Chem., 25(8): 1432-1435 (1979).
Gazdar, A. F. et al., Cancer Res., 41: 2773-2777 (1981).
Carney, D. N. et al., Cancer Res., 44: 5399-5403 (1984).
Carney, D. N. et al., Cancer Res., 45: 2913-2923 (1985).
Lillie, J. W. et al., Cell, 46: 1043-1051 (1986).
Moran, E. and M. B. Mathews, Cell, 48: 177-178 (1987).
White, P. et al., Nature, 334: 124-129 (Jul. 1988).
Kaye, F. J. et al., J. Clin. Invest., 79: 1412-1420 (1987).
Phelps, W. C. et al., Cell 53: 539-547 (May, 1988).
Phelps, W. C. et al., Functional and Sequence Similarities Between HPV-16 E7 and Adenovirus E1A, In: Transforming Proteins of DNA tumor Viruses, Current Topics in Microbiol. and Immunol., vol. 144, (1989), R. Knippers and A. J. Kevine (Eds.), Springer-Verlag, Berlin, pp. 153-166.
von Knebel Doeberitz, M. et al;, Cancer Res., 48: 3780-3786, (Jul. 1988).
Kleinheinz et al., Human Papillomavirus Early Gene Products and Maintenance of the Transformed State of Cervical Cancer Cells In Vitro, In: Transforming Proteins of DNA Tumor Viruses, Current Topics in Microbiol. and Immunol., vol. 144, (1989), R. Knippers and A. J. levine (eds.), Springer-Verlag, Berlin, pp. 179-179.
Dyson, N. et al., Science, 243: 934-937 (Feb. 17, 1989).
Ch'ng, J. L. C. et al., Proc. Natl. Acad. Sci, U.S.A., 86: 10006-10010 (Dec. 1989).
Colberg-Poley, A. M. and Santomenna, L. D., Virology, 166(1):217-228 (1988).
Ishiguro, Y. et al., Cancer, 65: 2014-2019 (May 1990).
Burbaum Jonathan J.
Kaddurah-Daouk Rima
Lillie James W.
Amira, Inc.
Nutter Nathan M.
LandOfFree
Method of inhibiting transformation of cells in which purine met does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting transformation of cells in which purine met, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting transformation of cells in which purine met will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2377610